Efficacy and safety of risankizumab versus methotrexate in patients with moderate-to-severe plaque psoriasis: results from IMMbrace, a randomized, double-blind, phase 3 study with an open-label extension period in Brazil
巴西一项随机、双盲、3期临床试验（含开放标签扩展期）结果显示，risankizumab 与甲氨蝶呤治疗中重度斑块状银屑病患者的疗效和安全性存在差异。
期刊:Anais Brasileiros De Dermatologia
影响因子:3.6
doi:10.1016/j.abd.2024.08.002
Cestari, Tania F; Souza, Cacilda da Silva; Azulay-Abulafia, Luna; Romiti, Ricardo; Carvalho, André V E; Silva de Castro, Caio César; Marques, Sílvio Alencar; Antonio, João Roberto; Fabrício, Lincoln; Soliman, Ahmed M; Wu, Tianshuang; Sinvhal, Ranjeeta; Stakias, Vassilis; Song, Alexandra P; Kalabic, Jasmina; Martin, Naomi; Oyafuso, Luiza Keiko Matsuka
